throbber
Available online at www.sciencedirect.com
`
`SCIENCE @DIRECTO
`
`ELSEVIER
`
`International Journal of Pharmaceutics 269 (2004) 509-522
`
`international
`journal of
`pharmaceutics
`
`www.elsevier.com/locate/ijpharm
`
`Physicochemical properties and mechanism of drug release
`from ethyl cellulose matrix tablets prepared by
`direct compression and hot-melt extrusion
`Michael M. Crowley a,*, Britta Schroeder b, Anke Fredersdorfb, Sakae Obara c,
`Mark Talarico d, Shawn Kucera a, James W. McGinity a
`a Division of Pharmaceutics, College of Phannacy, The University of Texas at Austin, Austin, TX 78712, USA
`b College of Pharmacy, Freie Universitat Berlin, Berlin, Gennany
`c Shin-Etsu Chemical Co. Ltd., Specialty Chemicals Research Center, Niigata 942-8601, Japan
`d Micromeritics Instrument C01p., One Micromeritics Drive, Norcross, GA 30093-1877, USA
`Received 19 March 2003; received in revised fonn 16 September 2003; accepted 26 September 2003
`
`Abstract
`
`The objective of this research project was to determine the physicochemical properties and investigate the drug release
`mechanism from ethyl cellulose (EC) matrix tablets prepared by either direct compression or hot-melt extrusion (HME) of
`binary mixtures of water soluble drug (guaifenesin) and the polymer. Ethyl cellulose was separated into "fine" or "coarse"
`particle size fractions corresponding to 325-80 and 80-30 mesh particles, respectively. Tablets containing 30% guaifenesin were
`prepared at 10, 30, or 50 kN compaction forces and extruded at processing temperatures of 80-90 and 90-110 °C. The drug
`dissolution and release kinetics were determined and the tablet pore characteristics, tortuosity, thermal properties and surface
`morphologies were studied using helium pycnometry, mercury porosimetry, differential scanning calorimetry and scanning
`electron microscopy. The tortuosity was measured directly by a novel technique that allows for the calculation of diffusion
`coefficients in three experiments. The Higuchi diffusion model, Percolation Theory and Polymer Free Volume Theory were
`applied to the dissolution data to explain the release properties of drug from the matrix systems. The release rate was shown to
`be dependent on the ethyl cellulose particle size, compaction force and extrusion temperature.
`© 2003 Elsevier B.V. All rights reserved.
`
`Keywords: Hot-melt extrusion; Guaifenesin; Ethyl cellulose; Matrix tablets; Higuchi diffusion model; Porosity; Tortuosity; Percolation; Free
`volume; Sustained release; Mercury porosimetry
`
`1. Introduction
`
`Ethyl cellulose (EC) is a non-toxic, stable, com-
`pressible, inert, hydrophobic polymer that has been
`widely used to prepare pharmaceutical dosage forms.
`
`* Corresponding author. Tel.: + 1-512-471-6834;
`fax: +1-512-471-7474.
`E-mail address: mmcrowley@mail.utexas.edu (M.M. Crowley).
`
`The properties of ethyl cellulose sustained release
`products, including film coated tablets (Rowe, 1992),
`microspheres (Akbuga, 1991; Eldridge et al., 1990),
`microcapsules (Jalsenjak et al., 1977) and matrix
`tablets for both soluble and poorly soluble drugs
`(Shaikh et al., 1987a,b) have been reported.
`Hot-melt extrusion (HME) is a widely used pro-
`cess in the plastics industry to produce tubing, pipes
`and films. In pharmaceutical systems, HME has been
`
`0378-5173/$- see front matter© 2003 Elsevier B.V All rights reserved.
`doi: 10.1 016/j .ijphann.2003.09.037
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`510
`
`MM Crowley eta!. /International Journal of Pharmaceutics 269 (2004) 509-522
`
`used to prepare granules, sustained-release tablets,
`and transdermal drug delivery systems (AitkenNichol
`et al., 1996; Follonier et al., 1994; McGinity et al.,
`2000; Zhang and McGinity, 1999, 2000). It has been
`demonstrated that the processing method can dictate
`the porosity and pore structure of the dosage form
`(Selkirk and Ganderton, 1970; Zoglio and Carstensen,
`1983). Previous workers have also shown that thermal
`processing results in a more tortuous product (Rubio
`and Ghaly, 1994; Zhang et al., 2001).
`Several researchers have suggested that diffusion
`controlled sustained release dosage forms prepared by
`HME have slower drug release rates than those pre-
`pared by traditional methods due to lower porosity and
`higher tortuosity (Young et al., 2002). Polymeric ma-
`terials are softened or molten during hot-melt extru-
`sion and subjected to intense mixing resulting in the
`generation of high pressures. Air present in the pow-
`der bed can be excluded from the polymer melt during
`hot-melt extrusion. As a result, HME dosage forms are
`expected to have a lower porosity and higher tortuos-
`ity, in comparison with the dosage forms prepared by
`tabletting processes.
`The Higuchi Square Root Model (Higuchi, 1963)
`has been successfully applied to model the kinetics
`of drug release from matrix systems. The Eq. (1) was
`derived from Fick' s Law of diffusion and applied to
`porous hydrophobic polymeric drug delivery systems
`in homogenous matrices and granular matrices.
`
`Q(t) = J D,C.~(2Co- sCa)t
`= J DappCa(2Co- cCa)t = k.Ji
`
`(1)
`
`In Eq. (1), Q(t) represents the cumulative amount of
`drug released at time t per unit surface area, Ds denotes
`the drug diffusion coefficient in the release medium,
`Co the total amount of drug in the matrix, Ca the sol-
`ubility of the drug in the release media, 8 the porosity,
`r the tortuosity of the matrix, Dapp the apparent or ob-
`served diffusion coefficient (Dapp = Dsc/r) and k the
`dissolution rate constant. Drug release can be manip-
`ulated by varying: (a) the initial concentration of drug
`within matrix; (b) porosity; (c) tortuosity; (d) the poly-
`mer system forming the matrix; and (e) the solubility
`of the drug.
`Drug release from a porous, hydrophobic polymeric
`drug delivery system occurs when the drug comes
`
`into contact with the release media, subsequently dis-
`solves and diffuses through media filled pores. Thus,
`the geometry and structure of the pore network are
`important in this process (Dees and Polderman, 1981;
`Lowenthal, 1972). The Higuchi model has been re-
`ported to fail at drug loading levels below the percola-
`tion threshold (Zhang and McGinity, 2000). Below the
`percolation threshold, incomplete drug release is ob-
`served presumably due to limited accessibility of many
`drug particles to the dissolution medium since they are
`encapsulated by water insoluble polymeric materials.
`The objectives of the present study were to deter-
`mine the physicochemical properties of ethyl cellulose
`matrix tablets prepared by either direct compression
`or hot-melt extrusion in order to explain the drug re-
`lease mechanism. The influence of compaction force
`and processing temperature on drug release rates and
`the physical properties of the tablets was studied. The
`effect of ethyl cellulose particle size was examined
`in tablets prepared by both direct compression and
`hot-melt extrusion. The median pore size, porosity and
`tortuosity of the matrix tablets prepared by the two
`techniques were determined using the Webb technique
`allowing calculation of the diffusion coefficients.
`
`2. Theory of mercury intrusion porosimetry and
`tortuosity
`
`Knowledge of tortuosity is necessary to determine
`diffusion coefficients from observed dissolution data.
`Researchers have relied upon secondary methods to
`determine tortuosity. These techniques required sev-
`eral steps and were time intensive. Recently, a novel
`approach using mercury intrusion porosimetry for di-
`rect measurement of tortuosity was reported (Webb,
`2001b). Mercury intrusion porosimetry has been used
`to study the pore characteristics of tablets (Gucluyildiz
`et al., 1977; Selkirk and Ganderton, 1970; Wikberg
`and Alderbom, 1992), granules (Opakunle and Spring,
`1976; Zoglio and Carstensen, 1983), ceramic particles
`for sustained drug delivery (Byrne and Deasy, 2002)
`and excipients (Riepma et al., 1993). The technique
`is based upon the unique properties of mercury. Mer-
`cury behaves as a non-wetting liquid toward most sub-
`stances and will not penetrate a solid unless pressure
`is applied. For circular pore openings, the Washburn
`Eq. (2) (Washburn, 1921) relates the applied pres-
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`MM Crowley et a!. !International Journal of Pharmaceutics 269 (2004) 509-522
`
`511
`
`K =
`
`(3)
`
`r=
`
`(2)
`
`sure, P, and the radius, r, of the pores intruded with a
`non-wetting liquid:
`-2ycose
`p
`where y is the surface tension of mercury and e the
`contact angle between the liquid and sample. The in-
`verse relationship between pore radius and applied
`pressure indicates low pressures are used to measure
`large pore sizes and high pressures are used to mea-
`sure small pore sizes.
`Katz and Thompson (Katz and Thompson, 1986;
`Thompson et al., 1987) introduced an expression (3)
`for determination of permeability in porous rocks
`from mercury intrusion curves based upon con-
`cepts from Percolation Theory (Broadbent and Ham-
`mersley, 1957; Hammersley, 1957). These researchers
`found that absolute permeability, K, was related to
`the rock conductivity at a characteristic length Lc.
`Lmax
`¢S(Lmax)
`89 X Lc
`Eq. (3) requires dete1mination of the length at which
`conductance is at a maximum, Lmax, and the fraction
`of total porosity, ¢, filled at this length S(Lmax). The
`characteristic length, Lc, is the length at which mer-
`cury spans the entire sample and was found to be the
`point at which percolation begins. It is determined
`at the point of inflection in the rapidly rising region
`of the cumulative intrusion curve. Several different
`scientific disciplines have used the Katz-Thompson
`method to determine permeability in a variety of mate-
`rials (Bentz et al., 1998; Berkowitz and Balberg, 1993;
`Budd, 2002; Celzard et al., 2002; Garboczi and Bentz,
`2001).
`Jorgen Hager also derived an expression for mate-
`rial permeability based upon a capillary bundle model
`and knowledge of material tortuosity (Hager, 1998).
`The capillary bundle model describes the pore net-
`work as homogenously distributed in random direc-
`tions. Using the Hagen-Poiseuille correlation for fluid
`flow in cylindrical geometries in combination with
`Darcy's Law, Hager was able to derive an Eq. (4) for
`permeability, K, in terms of total pore volume, Vtot,
`material density, p, pore volume distribution by pore
`size, r~~~c.m_ax ry2 fv(ry) dry, and material tortuosity, T. In
`J 1}-1 c,rrun
`this method, Hager obtained all parameters except tor-
`tuosity from mercmy intrusion porosimetry analysis.
`
`K =
`
`1ry=rc,max
`1l fv(1J) dry
`
`(4)
`
`p
`24-r (1 + P Vtot)
`2
`lJ=rc min
`Webb concluded that combining the Hager and
`Katz-Thompson expressions (Eq. (5)) provided a
`means for determining tortuosity from mercury intru-
`sion porosimetry data (Webb, 2001a,b).
`
`r=
`
`11J=rc,max ryl fv(1J) dry
`lJ= rc,min
`
`(5)
`
`p
`24 K (1 + P Vfot)
`Since the determination of tortuosity depends upon
`permeability, changes in material permeability during
`the analysis will affect the reported value for tortuos-
`ity. Webb also reported that improved accuracy was
`achieved using true density data from helium pycnom-
`etry. Thus, the Webb technique allows determination
`of tortuosity from only two experiments, helium pyc-
`nometly and mercury intrusion. The apparent diffusion
`coefficient and diffusion coefficient can then be calcu-
`lated using the rate constant from dissolution studies.
`
`3. Experimental
`
`3.1. Materials
`
`Guaifenesin and glacial acetic acid were purchased
`from Spectrum Laboratory Products (Gardenia, CA).
`Ethyl cellulose grade Standard 10 (48.0--49.5%
`ethoxyl substitution, 9- 11 cP. viscosity range) was
`kindly donated by the Dow Chemical Company (Mid-
`land, MI). Methanol was purchased from EM Science
`(Gibbstown, NJ).
`
`3.2. Methods
`
`3.2.1. Preparation oftablets
`Ethyl cellulose was sieved into two fractions. The
`"coarse" fraction included the material that passed
`through a 30 mesh screen and was retained by an 80
`mesh screen. The "fine" fraction included material that
`passed through 80 mesh screen and was retained on
`a 325 mesh screen. Guaifenesin was passed through a
`30 mesh screen prior to use. The ethyl cellulose par-
`ticle size fractions were confirmed by introducing an
`aqueous suspension of ethyl cellulose to laser light
`scattering using a Malvern Mastersizer S (Malvern In-
`struments Limited, Malvern, Worcestershire, UK).
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`512
`
`MM Crowley et al. /International Journal of Pharmaceutics 269 (2004) 509-522
`
`A model formulation containing 30% guaifenesin
`and 70% ethyl cellulose was selected for this study.
`The drug and polymer were geometrically diluted in
`a glass mortar and pestle and then introduced into
`a V Blender (Blend Master®, Patterson-Kelley, East
`Stroudsburg, PA) and mixed for 15 min. Tablets were
`prepared from the resultant blend by either direct com-
`pression or via hot-melt extrusion.
`
`3.2.2. Direct compression process
`Tablet compacts were prepared using a Carver
`25 Ton laboratory press (Fred Carver, Menomonee
`Falls, WI) and a 6 mm diameter flat faced punch and
`die set. The force applied on the punches was mea-
`sured using a load cell (ISI Inc., Round Rock, TX)
`mounted directly on the press with strain gauge sen-
`sors. Tablets weighing 250 ± 5 mg were compressed
`to 10, 30 or 50 kN for 3 s and ejected from the die.
`
`3.2.3. Hot-melt extrusion process
`The powder blend was fed into a single-screw Rand-
`castle Extruder (Model RC 0750, Cedar Grove, NJ)
`equipped with a Nitralloy 135M screw (3:1 compres-
`sion ratio with flight configuration containing feed,
`compression and mixing sections) and a rod shaped
`die (6 mm in diameter). The screw speed was 20 rpm.
`The three heating zones and die temperatures were set
`and allowed to equilibrate. Samples were prepared us-
`ing two different processing temperature ranges: "low"
`(80, 85, 85, 90 °C) and "high" (90, 105, 105, 110 °C).
`The residence time of the materials in the extruder was
`approximately 2-3 min. The extrudates were cooled
`to 45-55 oc and manually cut into tablets weighing
`250 ± 5mg.
`
`3.2.4. In vitro release properties
`Dissolution testing was performed using apparatus
`II on a Van Kel VK7000 Dissolution Tester (VanKel
`Industries, Edison, NJ) equipped with an auto sampler
`(Model VK 8000) according to the guaifenesin tablet
`monograph in USP 24. Six tablets were placed into the
`dissolution medium (900 ml of purified water) which
`was maintained at 37 oc by a circulating bath (Van
`Kel Model 750D) and agitated at 50 rpm. Samples
`(5 ml) were removed at specified time points over a
`12 h period without media replacement.
`Samples were analyzed for guaifenesin content us-
`ing a Waters (Milford, MA) high performance liquid
`
`chromatography (HPLC) system with a photodiode
`array detector (Model996) extracting at 276 run. Sam-
`ples were pre-filtered through a 0.45 1-Lm membrane
`(Gelman Laboratory, GHP Aero disc). An auto sampler
`(Model 717plus) was used to inject 20 1-11 samples. The
`data were collected and integrated using Empower®
`Version 5.0 software. The column was an Alltech
`Alltima™ cl8 3j.Lm, 150mm X 4.6mm. The mobile
`phase contained a mixture of water:methanol:glacial
`acetic acid in volume ratios of 600:400:15. The sol-
`vents were vacuum filtered through a 0.451-Lm nylon
`membrane and degassed by sonication. The flow rate
`was 1.0 mVmin. The retention time of the guaifen-
`esin was 4 min. Linearity was demonstrated from 2
`to 200 j..Lg/ml (R2 ~ 0.997) and injection repeata-
`bility was 0.35% relative standard deviation for 10
`injections.
`
`3.2.5. True density by helium pycnometry
`The true density of the powder formulations and
`tablets was determined in triplicate using helium pyc-
`nometry (Micromeritics ® AccuPyc 1330 Pycnometer;
`Norcross, GA). Twelve tablets were placed in a 12 cm3
`sample cup and purged 20 times at 19.85 psi followed
`by six analytical runs at 19.85 psi. The equilibration
`rate was 0.0050 psi/min. An equivalent mass of the
`powder mixtures was measured in the same manner.
`
`3.2. 6. Mercury intrusion porosimetry
`The bulk density and tortuosity of the tablets were
`determined using an AutoPore IV 9500 mercury intru-
`sion porosimeter (Micromeritics, Norcross, GA). In-
`cremental volumes of mercury were plotted against
`pore diameters according to the Washburn Eq. (2). A
`surface tension value of 485 Diem was used for mer-
`cury and its contact angle was 130°. Twelve tablets
`were placed in a Sec bulb penetrometer and pressure
`was applied from 1 to 15,000 psia, representing pore
`diameters of0.012-360 j..Lm. The pressure at each point
`was allowed to equilibrate for 10 s. Each run was per-
`formed in triplicate. Tablets were analyzed prior to and
`post-dissolution, with the removal of water from the
`tablets following dissolution by drying to a constant
`weight under vacuum for a minimum of 72 h.
`
`3.2. 7. Percent effective porosity determination
`Percent effective porosity, s was determined ac-
`cording to the Varner technique (Varner, 1991) us-
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`MM Crowley et al. I International Journal of Pharmaceutics 269 (2004) 509-522
`
`513
`
`ing Eq. ( 6) in which Pt is the true density of the
`tablet as determined by helium pycnometry and Ph
`the bulk density as determined by mercury intrusion
`porosimetry. Three runs of 12 tablets were analyzed
`first by helium pycnometry followed by mercury in-
`trusion porosimetry.
`
`of Moore and Planner for dissolution curve compari-
`son using the similarity (fi) and difference factors (/2)
`(Moore and Planner, 1996).
`
`4. Results and discussion
`
`£=
`
`Pt- Pb
`Pb
`
`(6)
`
`4.1. The influence of ethyl cellulose particle size on
`drug release
`
`3.2. 8. Modulated differential scanning calorimetry
`analysis
`scanning
`Temperature modulated differential
`calorimetry (M-DSC) was used to characterize the
`thermal properties of the polymer and drug in phys-
`ical mixtures and hot-melt extrudates. M-DSC anal-
`ysis was conducted using a Thermal Advantage
`Model 2920 from TA Instruments (New Castle, DE)
`equipped with Universal Analysis 2000 software. Ul-
`trahigh purity nitrogen was used as the purge gas at a
`flow rate of 150 mVmin. The sample was weighed to
`10 ± 5 mg and placed in aluminum pans (Kit 0219-
`0041, Perkin-Elmer Instruments, Norwalk, CT) and
`crimped with an aluminum lid. The temperature ramp
`speed was 2 °C/min from 25 to 150 oc for all studies
`with a modulation rate of 1.592 oc every minute.
`
`3.2.9. Scanning electron microscopy
`Scanning electron microscopy was used to study the
`surface morphology of the hot-melt extruded tablets.
`The samples were mounted on an aluminum stage us-
`ing adhesive carbon tape and placed in a low humid-
`ity chamber for 12 h prior to analysis. Samples were
`coated with gold-palladium for 60 s under an argon
`atmosphere using a Pelco® Model 3 Sputter Coater
`(Ted Pella Inc., Tusin, CA) in a high vacuum evapora-
`tor equipped with an omni-rotary stage tray. Scanning
`electron microscopy was performed using a Hitachi
`S-4500 field emission microscope operating at an ac-
`celerating voltage of 15 kV and a 15 J.LA emission cur-
`rent. Images were captured with Quartz® software.
`
`3.2.1 0. Statistical analysis
`One-way analysis of variance (ANOVA) was used to
`determine statistically significant differences between
`results. Results with P-values <0.05 were considered
`statistically significant (a= 0.05). Dissolution curves
`were analyzed by the model independent approach
`
`The influence of ethyl cellulose particle size and
`processing conditions on the release rate of guaifen-
`esin from matrix tablets was studied. The influence
`of ethyl cellulose particle size, compaction force and
`extrusion temp.erature on guaifenesin release rate
`is presented in Fig. 1. The guaifenesin release rate
`from the matrix was highly dependent upon ethyl
`cellulose particle size and the processing conditions
`employed to prepare the tablet. In both cases, slower
`release rates were observed with small particle size
`ethyl cellulose.
`According to Percolation Theory, when a matrix is
`composed of a water soluble drug and a water insolu-
`ble polymer, drug release occurs by dissolution of the
`active ingredient through capillaries composed of in-
`terconnecting drug particle clusters and the pore net-
`work (Holman and Leuenberger, 1988; Leuenberger
`et al., 1987). As drug release continues, the intercon-
`necting clusters increase the pore network through
`which interior drug clusters can diffuse. The total
`number of ethyl cellulose particles increases when its
`pmiicle size is reduced. With more ethyl cellulose
`particles present, the theory predicts that fewer clus-
`ters of soluble drug substance are formed. Further-
`more, the presence of finite drug clusters ( encap-
`sulated drug particles) is more statistically plausi-
`ble. The resulting pore network becomes less ex-
`tensive and more tortuous resulting in slower drug
`release.
`Mercury porosimetry and helium pycnometry were
`used to determine the pore characteristics and tor-
`tuosity of the tablets prior to dissolution testing.
`The median pore radius, percent effective porosity
`and tortuosity of the matrix tablets are presented in
`Table 1. Statistically significant differences in median
`pore radius (n = 3, P < 0.006), porosity (n = 3,
`P < 0.02) and tortuosity (n = 3, P < 0.009) were
`observed between matrix tablets prepared with "fine"
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`514
`
`MM Crowley et al. /International Journal of Pharmaceutics 269 (2004) 509-522
`
`'0
`Cl)
`
`II> m 60
`Cl)
`-a;
`
`a:::: -c: Cl)
`
`(.)
`r...
`Cl)
`D..
`
`80
`
`40
`
`20
`
`0
`
`2
`
`{A)
`
`4
`8
`6
`Time (Hours)
`
`10
`
`12
`
`0
`
`2
`
`(B)
`
`4
`
`8
`6
`Time (Hours)
`
`10
`
`12
`
`Fig. 1. Influence of ethyl cellulose particle size, compaction force
`and extmsion temperature on guaifenesin release from matrix
`tablets prepared by direct compression and hot-melt extmsion
`containing 30% guaifenesin and 70% ethyl cellulose using USP
`Method II at 3 7 o C and 50 rpm in 900 ml of purified water. Each
`point represents the mean± standard deviation, n = 6. (A) Matrix
`tablets prepared using "fine" ethyl cellulose (325-80 mesh) and
`(B) matrix tablets prepared using "coarse" ethyl cellulose (80--30
`mesh). (+) Direct compression, 10 kN; (.) direct compression,
`30 kN; ( ... ) direct compression, 50 kN; c•) hot-melt extmsion, 80,
`85, 85, 90 oc; (D) hot-melt extmsion, 90, 105, 105, 11 o oc.
`
`and "coarse" ethyl cellulose particle sizes. The me-
`dian pore radius was smaller, the tablets less porous
`and more tortuous when prepared with "fine" ethyl
`cellulose (137-529 A, 0.4-4.1% porosity and 4.7-321
`tortuosity) than in tablets prepared with "coarse"
`ethyl cellulose (351-1439 A, 0.7-6.5% porosity and
`1.3-125 tortuosity). These data are supported by the
`dissolution results.
`Katikaneni and coworkers (Katikaneni et al.,
`1995a,b; Upadrashta et al., 1993, 1994) reported that
`pseudoephedrine hydrochloride release from ethyl
`cellulose matrix tablets prepared by direct compres-
`sion was controlled by ethyl cellulose particle size
`and compression force. These authors concluded that
`the drug release rate decreased due to a reduction
`in porosity and increased matrix tortuosity at high
`compaction forces or when a finer particle of size
`ethyl cellulose was used. The findings in the present
`study confirm the work of Katikaneni, support the
`predictions of Percolation Theory and demonstrate
`the utility of the mercury porosimetry technique for
`determination of tortuosity.
`Generally, pore radii greater than 200 A are neces-
`sary to avoid hindered diffusion (Anderson and Quinn,
`1974). Hindered diffusion can be due to steric exclu-
`sion or hindered particle motion. In these situations,
`either the pore radii are sufficiently small that the
`molecular dimensions of the solute restrict its diffu-
`sion or excessive frictional resistance is created. Hin-
`dered diffusion is typically observed when values of
`the particle radius to pore wall radius ratio are greater
`than 0.1. The molecular dimensions of guaifenesin
`were modeled using SAVOL3 software to assess the
`likelihood of hindered diffusion (Pearlman and Skell,
`2003). Assuming a spherical shape, guaifenesin was
`found to have a radius of 3.53 A excluding a solvent
`radius and 5.44 A with a solvent radius. Assuming
`an ovoid shape and including a solvent radius, the
`model predicted the major axis to be 7. 84 A, the first
`minor axis to be 6.13 A and the second minor axis
`to be 3.89 A. Thus, the minimum guaifenesin particle
`radius to pore radius ratio is 0.04 in the case of the
`hot-melt extruded tablets prepared using "fine" ethyl
`cellulose and processed at 90-110 °C. This value
`is sufficiently small that hindered diffusion can be
`considered negligible.
`Several assumptions are made using the mercury
`porosimetry technique which can introduce consid-
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`MM Crowley et al. / International Journal of Pharmaceutics 269 (2004) 509-522
`
`515
`
`Table 1
`Median pore radius, percent porosity and tortuosity of matrix tablets prepared by direct compression (DC) and hot-melt extrusion (HME)
`containing 30% guaifenesin and 70% ethyl cellulose measured before and after dissolution testing
`
`Processing conditions
`
`Median pore radius (A)
`
`Before
`
`After
`
`Percent porosity
`
`Before
`
`After
`
`Tortuosity
`
`Before
`
`4.7±1.1
`6.0 ± 0.6
`6.9 ± 0.9
`53.2 ± 8.1
`321 ± 22
`
`1.3 ± 0.7
`2.1 ± 0.6
`2.8 ± 0.5
`41.8 ± 5.5
`125 ± 16
`
`After
`
`4.7 ± 0.6
`5.2 ± 0.9
`
`4.4 ± 0.3
`5.0 ± 1.1
`
`4.1 ± 0.3
`3.8 ± 0.2
`3.1 ± 0.2
`1.0 ± 0.2
`0.4 ± 0.2
`
`6.5 ± 0.2
`5.7 ± 0.3
`5.2 ± 0.2
`2.3 ± 0.4
`0.7 ± 0.1
`
`8.1 ± 1.8
`7.8 ± 2.2
`
`8.7 ± 1.4
`8.0 ± 1.1
`
`"Fine" ethyl cellulose (325-80 mesh)
`DC lOkN
`529 ± 24
`DC 30kN
`476 ± 26
`DC 50kN
`475 ± 17
`HME 80, 85, 85, 90 ac
`264± 8
`HME 90, 105, 105, 110 ac
`137±6
`"Coarse" ethyl cellulose (80-30 mesh)
`DC 10kN
`1439 ± 42
`DC 30kN
`906 ± 23
`DC 50kN
`710 ± 25
`HME 80, 85, 85, 90 ac
`642 ±48
`392 ± 11
`HME 90, 105, 105, 110 ac
`588 ±57
`351 ± 13
`Each point represents the mean± standard deviation, n = 3.
`
`575 ±51
`521 ± 65
`
`erable error into the measurements. The assumption
`of circular pore cross-sections or "cylindrical pore
`geometry" is due to mathematical convenience in
`order to avoid complexities calculating mean radii
`and contact angles in irregularly shaped pores. As
`a result, the technique is biased to calculate smaller
`pore sizes than are actually present. Furthermore,
`"ink bottle pores" also bias the pore size calculation
`to the small side. Ink bottle pores are defined as
`pores in which the diameter increases as one moves
`to its inner dimensions (Leon, 1998; Salmas and
`Androutsopoulos, 2001). Mercury intrusion also in-
`volves subjecting the tablets to equal pressures from
`360° as the mercury is forced inside. This means
`that as mercury intrudes into the pores, the walls of
`pores penetrated by mercury at a given pressure are
`uniformly affected by the same pressure. This makes
`collapse of a pore wall unlikely. However, the tablet
`can compress under the applied pressure which allows
`for additional mercury to intrude. This also biases
`measurement to calculation of smaller than actual
`pore size. Obviously, the compression of ethyl cellu-
`lose is a concern using this technique. To minimize
`the impact of tablet compression, the applied pressure
`was not allowed to exceed that applied during the di-
`rect compression experiments (50 kN or 15,000 psia).
`Despite these limitations, pore size information ob-
`tained from mercury porosimetry experiments has
`been consistently demonstrated to be representative.
`
`4.2. The Influence of tableting technique on drug
`release
`
`Guaifenesin release rates were considerably slower
`in tablets prepared by hot-melt extrusion than those
`prepared by direct compression as shown in Fig. I.
`Statistically significant differences in median pore
`radius (n = 3, P < 0.006), percent effective poros-
`ity (n = 3, P < 0.002) and tortuosity (n = 3,
`P < 0.0004) were observed between the direct com-
`pression and hot-melt extruded tablets as shown in
`Table 1. The median pore radius was smaller and the
`tablets less porous when prepared by hot-melt extru-
`sion (137-392 A, 0.4-2.3% porosity and 41.8-321
`tortuosity) than by direct compression (475-1439 A,
`3.1-6.5% porosity and 1.3-6.9 tortuosity). Adsorption
`and binding studies did not reveal any interactions.
`Complete drug recovery was obtained in samples
`dissolved in ethanol. Thus, the differences in release
`rate are due to the bonding mechanism of the parti-
`cles in the two tableting techniques. Ethyl cellulose
`has been reported to be ductile and the predominant
`mechanism during compaction is plastic deformation
`(Katikaneni et al., 1995b). During hot-melt extrusion,
`solid bridges are formed upon cooling.
`The extrusion temperatures were above the melt-
`ing point of guaifenesin but below the glass transition
`temperature of ethyl cellulose. The molten drug can
`act as a solvent for the polymeric particles. Polymeric
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`516
`
`MM Crowley et a!. I International Journal of Pharmaceutics 269 (2004) 509-522
`
`particles that do not go into solution are softened at
`elevated temperatures and deformed by the rotating
`screw during extrusion. Upon cooling, extensive solid
`bridges are formed between the particles resulting in a
`smaller pore radius and more tortuous network. These
`results demonstrate that densification of the molten
`mass during extrusion occurs to a greater extent rela-
`tive to compaction of the powder during compression.
`Thermal treatment of amorphous polymers has
`also been shown to decrease polymer free volume
`(Follonier et al., 1995). Elevated temperatures and
`high pressures during hot-melt extrusion followed by
`cooling significantly impact the free volume. Polymer
`chain motion and free volume increase with temper-
`ature allowing molten guaifenesin molecules to enter
`these voids. Upon cooling, the guaifenesin molecules
`
`remain dispersed in these domains. The net effect is
`an increase in the degree of packing and a reduc-
`tion in free volume. Diffusion of molecules through
`amorphous polymers is governed by free volume and
`packing. Thus, a decrease in drug transport is antic-
`ipated when the free volume decreases and packing
`order increases.
`The miscibility of guaifenesin in ethyl cellulose was
`studied by modulated differential scanning calorime-
`try. The glass transition temperature of ethyl cellulose
`was found to be 129.3 oc (Fig. 2A) and the melting
`point of guaifenesin was found to be 85.6 oc (Fig. 2B).
`The melting point of guaifenesin can be observed in
`the thermograms of the physical mixtures (Fig. 2C
`and F). Thermo grams of the hot-melt extrudates pro-
`cessed at 80-90 °C show a melt transition about 9 oc
`
`3.750
`
`3.125
`
`2.500
`
`1.875
`
`1.250
`
`...........
`C)
`
`0.625
`~ 0.000
`~ -0.625
`u::
`1ii
`(I)
`I
`
`-1.250
`
`-1.875
`
`-2.500
`
`-3.125
`
`-3.750
`
`-4.375
`
`-5.000
`20
`
`ExoUp
`
`A
`
`B
`
`c
`
`129.27"C(I)
`
`85.64°C
`
`D ~
`
`aa.saoc
`~---------------------~
`
`E
`
`77.52°C
`
`F
`
`86.73°C
`
`75.16°C
`
`40
`
`60
`
`100
`80
`Temperature ("C)
`
`120
`
`160
`140
`Universal V3.0G TA lnstrum ents
`
`Fig. 2. Modulated differential scanning calorimetry profiles of ethyl cellulose, guaifenesin, physical mixtures and hot-melt extrudates. (A)
`Ethyl cellulose; (B) guaifenesin; (C) physical mixture of 30% guaifenesin and 70% "coarse" ethyl cellulose; (D) hot-melt extrudate of 30%
`guaifenesin and 70% "coarse" ethyl cellulose processed at 80, 85, 85, 90 °C; (E) hot-melt extrudate of 30% guaifenesin and 70% "coarse"
`ethyl cellulose processed at 90, 105, 105, l10 °C; (F) physical mixture of 30% guaifenesin and 70% "fine" ethyl cellulose; (G) hot-melt
`extrudate of 30% guaifenesin and 70% "fine" ethyl cellulose processed at 80, 85, 85, 90 oc; (H) hot-melt extrudate of 30% guaifenesin
`and 70% "fine" ethyl cellulose processed at 90, 105, 105, 110 °C.
`
`KASHIV1060
`IPR of Patent No. 9,492,393
`
`

`

`below the melting point of guaifenesin (Fig. 2D and
`G). Thermal transitions corresponding to the melting
`point of guaifenesin are not observed in the extrudates
`processed at 90-100 oc (Fig. 2E and H). These results
`indicate that guaifenesin was miscible with ethyl cel-
`lulose while in the molten state. The presence of a tran-
`sition in the hot-melt extrudates processed at 80-90 oc
`suggests that a two phase solid dispersion was formed
`in which guaifenesin was present in both amorphous
`and crystalline fmm. The absence of a transition in the
`extrudates processed at high

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket